Metastatic breast cancer days - 13engagée meeting days
Why have a day dedicated to metastic breast cancers?
Metastic breast cancer (or stage IV breast cancer) means that cancer cells from the initial breast tumor (primary tumor) have detached and spread to one or several other body parts, where they formed new tumors. These news tumors are called metastasis. It is not a second cancer but the same initial breast cancer that has spread.
Thanks to the progress of research and medicine, treatments have been developed to limit the progression of the disease and improve the quality of life of the people affected by it. Currently, this type of cancer is not curable (meaning that we can’t eradicate all traces of cancer) but its progression can be controlled and stabilized with treatments, for several years, making metastatic disease a chronic disease.
This highlights the specific features of metastatic breast cancers for which patient concerns and issues are very different from the ones for localized breast cancers.
The SIRIC Curie and the 1310 Collective organise the first national metastatic breast cancer day
This is why the 1310 Collective and the SIRIC Curie’s health democracy group, under the impetus of its patient representatives, wished to launch a meeting day dedicated to these cancers to highlight their characteristics and create dialogue space between the communities around the needs and issues at stake.
In 2019, the first patient – clinician – researcher event addressing the disease on a scientific level (clinical care, advances in research) but also on a “life path and support” level, was organized in France, in the context of the international metastatic breast cancer day (13th October). It has become an annual event.
(Re)watch the presentations of previous editions (videos are in French) :
